Almac Group

Almac Group is a privately owned contract development and manufacturing organisation providing integrated services across the drug development lifecycle to pharmaceutical and biotechnology clients.

Capabilities span API and peptide synthesis, formulation development, GMP clinical and commercial manufacturing, clinical trial supply, biomarker discovery, companion diagnostic development, and eClinical technologies.

With over 7,500 employees across 18 global facilities, Almac has contributed to more than half of all FDA-approved new molecular entities in the past five years.